Changes in Psychotropic Drug Concentrations Across the Menstrual Cycle: A Pilot Study

Area of Science:

• Neuroscience
• Pharmacology
• Women's Health

Background:

• Psychopharmacological medication prescriptions for women of reproductive age are increasing.
• Clinical trials have historically overlooked sex-specific variations in drug response.
• Emerging data suggest sex-based differences in affective disorder neurobiology and drug metabolism.

Purpose of the Study:

• To investigate menstrual cycle-dependent fluctuations of psychotropic drugs and hormones in female patients with affective disorders.
• To enhance understanding of the relationship between hormonal changes and drug pharmacokinetics.
• To inform the development of safer and more effective psychopharmacological therapies.

Main Methods:

• Blood samples were collected from 27 patients with affective disorders and 27 controls at three menstrual cycle phases.
• Depressive and manic symptoms were assessed.
• Hormone and drug concentrations were measured using mass spectrometry.

Main Results:

• Significant menstrual cycle variations in bupropion concentration were observed.
• A trend toward altered venlafaxine concentration was noted.
• Patients with affective disorders showed distinct hormone concentrations compared to controls, irrespective of contraceptive use, diagnosis, or medication.

Conclusions:

• This pilot study supports the importance of sex-specific approaches in psychopharmacology.
• Evidence suggests an interaction between sex hormones, psychotropic drugs, and affective disorder symptoms.
• Further research is warranted to optimize pharmacotherapy for women.